Found: 46
Select item for more details and to access through your institution.
Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01068-w
- By:
- Publication type:
- Article
Morphologic, immunophenotypic, and molecular genetic comparison study in patients with clonal cytopenia of undetermined significance, myelodysplastic syndrome, and acute myeloid leukemia with myelodysplasia‐related changes: A single institution experience
- Published in:
- International Journal of Laboratory Hematology, 2022, v. 44, n. 4, p. 738, doi. 10.1111/ijlh.13840
- By:
- Publication type:
- Article
"Waitlist mortality" is high for myeloma patients with limited access to BCMA therapy.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1206715
- By:
- Publication type:
- Article
Efficacy and safety of idecabtagene vicleucel in patients with relapsed–refractory multiple myeloma not meeting the KarMMa‐1 trial eligibility criteria: A real‐world multicentre study.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1293, doi. 10.1111/bjh.19302
- By:
- Publication type:
- Article
Time‐to‐event surrogate end‐points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 5, p. 587, doi. 10.1111/bjh.18568
- By:
- Publication type:
- Article
Metastatic Renal Cell Carcinoma Presenting as Painful Chewing Successfully Treated with Combined Nivolumab and Sunitinib.
- Published in:
- Permanente Journal, 2016, v. 20, n. 3, p. 112, doi. 10.7812/TPP/15-149
- By:
- Publication type:
- Article
Outcomes of autologous stem cell transplant for cardiac AL-amyloidosis and cardiac light chain deposition disease.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1128, doi. 10.1177/1078155219888564
- By:
- Publication type:
- Article
Pazopanib- and bevacizumab-induced reversible heart failure in a patient with metastatic renal cell carcinoma: A case report.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Ipilimumab-induced necrotic myelopathy in a patient with metastatic melanoma: A case report and review of literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 3, p. 537, doi. 10.1177/1078155215572932
- By:
- Publication type:
- Article
Use of endpoints in multiple myeloma randomized controlled trials over the last 15 years: A systematic review.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 6, p. 690, doi. 10.1002/ajh.26166
- By:
- Publication type:
- Article
Improving Communication on Intent of Chemotherapy Using QOPI Scores and PDSA Cycles.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comparative Meta-Analysis of Triplet vs. Quadruplet Induction Regimens in Newly Diagnosed, Treatment Naïve, Multiple Myeloma.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2938, doi. 10.3390/cancers16172938
- By:
- Publication type:
- Article
Efficacy and Safety of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Compared to Daratumumab, Bortezomib, and Dexamethasone (DVd) in Daratumumab–Naïve Relapsed Multiple Myeloma.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4894, doi. 10.3390/cancers15194894
- By:
- Publication type:
- Article
Outcomes of Penta-Refractory Multiple Myeloma Patients Treated with or without BCMA-Directed Therapy.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2891, doi. 10.3390/cancers15112891
- By:
- Publication type:
- Article
Efficacy and safety of daratumumab, pomalidomide, and dexamethasone versus daratumumab, carfilzomib, and dexamethasone in daratumumab‐naïve relapsed multiple myeloma.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 6, p. 975, doi. 10.1111/ejh.14193
- By:
- Publication type:
- Article
Safety and efficacy of eltrombopag in patients with post‐CAR T cytopenias.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 4, p. 538, doi. 10.1111/ejh.14141
- By:
- Publication type:
- Article
Clinical efficacy of retreatment of daratumumab‐based therapy (D2) in daratumumab‐refractory multiple myeloma.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 6, p. 626, doi. 10.1111/ejh.13942
- By:
- Publication type:
- Article
Palliative care utilization, transfusion burden, and end‐of‐life care for patients with multiple myeloma.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 5, p. 559, doi. 10.1111/ejh.13843
- By:
- Publication type:
- Article
Neutralizing antibody responses against SARS‐CoV‐2 in patients with plasma cell disorders who are on active treatment after two doses of mRNA vaccination.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 5, p. 458, doi. 10.1111/ejh.13826
- By:
- Publication type:
- Article
Carfilzomib, cyclophosphamide, and dexamethasone (KCd) for the treatment of triple‐class relapsed/refractory multiple myeloma (RRMM).
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 6, p. 602, doi. 10.1111/ejh.13697
- By:
- Publication type:
- Article
Inpatient mortality of patients with multiple myeloma and renal impairment undergoing autologous stem cell transplantation.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 5, p. 571, doi. 10.1111/ejh.13487
- By:
- Publication type:
- Article
Antibiotic prophylaxis for patients with newly diagnosed multiple myeloma: Systematic review and meta‐analysis.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 5, p. 420, doi. 10.1111/ejh.13374
- By:
- Publication type:
- Article
Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma: A phase 1/2 study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 9, p. 10254, doi. 10.1002/cam4.5753
- By:
- Publication type:
- Article
Patterns of central nervous system involvement in relapsed and refractory multiple myeloma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Successful Treatment of Bing-Neel Syndrome Using Intrathecal Chemotherapy and Systemic Combination Chemotherapy Followed by BEAM Auto-Transplant: A Case Report and Review of Literature.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 4, p. 502, doi. 10.1016/j.clml.2013.03.002
- By:
- Publication type:
- Article
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Multiple Myeloma in HIV-Positive Patients in the Highly Active Antiretroviral Therapy Era: The Myeloma Institute of Research and Therapy Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 2, p. 171, doi. 10.1016/j.clml.2012.12.004
- By:
- Publication type:
- Article
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Hospitalization at the end of life in patients with multiple myeloma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Glass Wall: Gendered Authorship Disparities in CD 19 and BCMA CAR-T Clinical Trials for Lymphoma and Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. e344, doi. 10.1016/j.clml.2024.05.022
- By:
- Publication type:
- Article
Dampening Logistics Creating Inequitable Access: A Major Threat Despite Advancements.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. 348, doi. 10.1016/j.clml.2024.02.011
- By:
- Publication type:
- Article
Retrospective Review of Outcomes of Multiple Myeloma (MM) Patients With COVID-19 Infection (Two-Center Study).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 4, p. 273, doi. 10.1016/j.clml.2023.01.006
- By:
- Publication type:
- Article
Belantamab in Combination with Dexamethasone in Patients with Triple-class Relapsed/Refractory Multiple Myeloma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A Phase II Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. 775, doi. 10.1016/j.clml.2021.07.029
- By:
- Publication type:
- Article
A Systematic Review and Network Meta-analysis of Randomized Data on Efficacy of Novel Therapy Combinations in Patients with Lenalidomide-refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 7, p. 489, doi. 10.1016/j.clml.2021.03.006
- By:
- Publication type:
- Article
Outcomes of Daratumumab, Pomalidomide, and Dexamethasone, Followed by High-dose Chemotherapy and Autologous Stem Cell Transplantation, in Patients With Relapsed/Refractory Multiple Myeloma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Outcomes of VD-PACE With Immunomodulatory Agent as a Salvage Therapy for Relapsed/Refractory Multiple Myeloma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Outcomes of VDPACE with Immunomodulator Agent as a Salvage Therapy for Relapsed/Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S247, doi. 10.1016/j.clml.2018.07.145
- By:
- Publication type:
- Article
A novel prostate cancer immunotherapy using prostate-specific antigen peptides and Candida skin test reagent as an adjuvant.
- Published in:
- SAGE Open Medicine, 2018, v. 6, p. 1, doi. 10.1177/2050312118800202
- By:
- Publication type:
- Article
Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015–2020.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00750-1
- By:
- Publication type:
- Article
Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 10, p. 1, doi. 10.1038/s41408-020-00369-0
- By:
- Publication type:
- Article
Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation.
- Published in:
- Transfusion, 2024, v. 64, n. 8, p. 1402, doi. 10.1111/trf.17909
- By:
- Publication type:
- Article
Reporting of Postprotocol Therapies and Attrition in Multiple Myeloma Randomized Clinical Trials: A Systematic Review.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 4, p. e218084, doi. 10.1001/jamanetworkopen.2021.8084
- By:
- Publication type:
- Article
Waldenström's Macroglobulinemia Associated with Serum Amyloid A Protein Amyloidosis: Pitfalls in Diagnosis and Successful Treatment with Melphalan-Based Autologous Stem Cell Transplant.
- Published in:
- Acta Haematologica, 2013, v. 130, n. 3, p. 146, doi. 10.1159/000347036
- By:
- Publication type:
- Article
Single‐agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM‐2 trial.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3746, doi. 10.1002/cncr.34987
- By:
- Publication type:
- Article
Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 study.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 22, p. 4198, doi. 10.1002/cncr.33809
- By:
- Publication type:
- Article
Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary disease.
- Published in:
- EJHaem, 2021, v. 2, n. 4, p. 757, doi. 10.1002/jha2.275
- By:
- Publication type:
- Article